For example, it was reported that inhibiting AURKA enhances the chemosensitivity of cancer cells to the taxane and paclitaxel [30, 31], cisplatin [32], doxorubicin [33, 34], and 5-fluorouracil (5-Fu) [35]. The gene discussed is AURKA; the disease is cancer.